Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check4 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment is closed. The record history shows a new Revision: v3.6.0 and the removal of Revision: v3.5.5.SummaryDifference0.4%

- Check11 days agoChange DetectedA new revision label, v3.5.5, is now shown in the page history, replacing the previous v3.5.4. This indicates an internal update to the page's revision tracking.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows a revision label of v3.5.4, replacing the previous v3.5.3 in the Record History. This reflects a minor update to the page's revision metadata.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision label has been updated from v3.5.2 to v3.5.3, indicating a new software release. No study-specific details on the record history table appear to be changed.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision history updated: a new entry Revision: v3.5.2 was added, and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision v3.5.0 has been added and v3.4.3 removed in the study record history.SummaryDifference0.1%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.